Canada markets closed

Sirona Biochem Corp. (SBM.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.04500.0000 (0.00%)
At close: 10:38AM EDT
Full screen
Previous Close0.0450
Bid0.0450 x 0
Ask0.0500 x 0
Day's Range0.0400 - 0.0450
52 Week Range0.0400 - 0.1200
Avg. Volume44,961
Market Cap11.557M
Beta (5Y Monthly)-0.12
PE Ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings DateSept 27, 2024 - Oct 01, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateDec 27, 2006
1y Target EstN/A
  • GlobeNewswire

    GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report

    VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been featured in Stonegate Healthcare's newly published research report, "Novel Treatments for Age-Related Skin Problems." The report provides an in-depth analysis of the latest advancements in the $12.5 billion anti-aging skincare market. The research highlights GlycoProteMim alongside other

  • Newsfile

    Stonegate Healthcare Partners Announces Publication of Thematic Report on Anti-Aging Dermatology Innovations

    Dallas, Texas--(Newsfile Corp. - June 18, 2024) - Stonegate Healthcare Partners, a leading name in healthcare consultancy and market intelligence, is pleased to announce the publication of a comprehensive thematic report titled "Leading Innovations in Anti-Aging Dermatology." This report delves into the transformative advancements in the treatment of age-related skin conditions, focusing on cutting-edge technologies and personalized holistic ...

  • GlobeNewswire

    Sirona Biochem Engages Stonegate Healthcare Partners

    VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) has announced a partnership with Stonegate Healthcare Partners. Stonegate is a leading corporate advisory firm based in Dallas, Texas that offers research driven business development and investor outreach services. Leveraging Stonegate’s extensive global network of corporate and institutional investor relationships, Stonegate has begun an evaluation of Sirona’s anti-aging ingre